Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 USD | +1.74% | +15.84% | +20.00% |
06-20 | Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14% | MT |
05-09 | Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Femasys Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Femasys Inc.
HC Wainwright | |
JonesTrading Institutional Services | |
Chardan Research | |
Maxim | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- FEMY Stock
- Consensus Femasys Inc.